Friday, July 28, 2017
IBB 319.79 6.11 (1.87%)XBI 78.74 2.05 (2.54%)CNCR 22.88 1.13 (4.71%)
Ticker Current Price Change Graph
IBB 319.79 6.11 (1.87%)
XBI 78.74 2.05 (2.54%)
CNCR 22.88 1.13 (4.71%)
Last updated: ago
Sign in to Endpoints
Menu Search Chat
  • Special Reports
  • Deep Dives
  • ENDPOINTS 100
  • News
  • Protocols
  • Bioregnum
  • Thumbs Up/Down
  • About
  • Advertise
  • Privacy Policy
  • Reader center

J&J sews up an expanded vaccine pact with Bavarian Nordic, paying $43M for HIV, hep B projects

by John Carrollenvelope — on July 27, 2017 12:56 PM EDT

Alexion joins the R&D reorganization gala, pruning a slate of projects and revving up new deals

by John Carrollenvelope — on July 27, 2017 07:09 AM EDT
Updated: 07:53 AM

Sienna Bio bags $65M in the latest successful biotech IPO

by John Carrollenvelope — on July 27, 2017 06:55 AM EDT
Updated: 09:44 AM

UPDATED: AstraZeneca inks $8.4B pact with Merck as crucial MYSTIC study fails and shares plunge

by John Carrollenvelope — on July 27, 2017 02:23 AM EDT
Updated: 01:16 PM

Tetraphase lines up a new FDA pitch for antibiotic after it comes through in latest PhIII

by Arsalan Arifenvelope — on July 26, 2017 09:07 AM EDT
Updated: 09:08 AM

GSK CEO Walmsley is reorganizing R&D, dropping drugs and adding a new focus on cancer research

by John Carrollenvelope — on July 26, 2017 07:14 AM EDT
Updated: 08:21 AM

British billionaire Jim Mellon and high-profile partners roll the dice on an anti-aging upstart

by John Carrollenvelope — on July 26, 2017 07:00 AM EDT

Biogen lays out a plan to “streamline” ops, add $400M to fund neurosciences R&D, new deals

by John Carrollenvelope — on July 25, 2017 07:50 AM EDT
Updated: 10:07 AM

Restructuring the pipeline, Eli Lilly says a baricitinib comeback in rheumatoid arthritis could take years

by John Carrollenvelope — on July 25, 2017 06:44 AM EDT
Updated: 09:50 AM

Trading places with Bristol-Myers, Merck hit with another late-stage setback on checkpoint star Keytruda

by John Carrollenvelope — on July 24, 2017 05:41 PM EDT
Updated: July 25, 2017 06:15 AM

  • 1
  • 2
  • 3
  • 65

Contact Endpoints News

You can also contact John Carroll, Editor at john@endpointsnews.com

← Go back
  • About
  • Privacy Policy
  • Media Kit

copyright 2017 Endpoints Company

Yes, I'd like to subscribe No, thanks
I'm already a subscriber
Thank you for staying with us. It's great to have you on board!
Aww, shucks. Perhaps you can tell us what we could do to make you interested in subscribing?
Sure No
← Go back

Sign-in with a magic link

One-time use, expires in minutes.